236 related articles for article (PubMed ID: 7815566)
1. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs.
Robertson E; Kieff E
J Virol; 1995 Feb; 69(2):983-93. PubMed ID: 7815566
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus recombinants from overlapping cosmid fragments.
Tomkinson B; Robertson E; Yalamanchili R; Longnecker R; Kieff E
J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
[TBL] [Abstract][Full Text] [Related]
3. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
Robertson ES; Tomkinson B; Kieff E
J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
Cohen JI; Picchio GR; Mosier DE
J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
Cohen JI; Wang F; Kieff E
J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
[TBL] [Abstract][Full Text] [Related]
6. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
Tomkinson B; Kieff E
J Virol; 1992 Feb; 66(2):780-9. PubMed ID: 1309912
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.
Marchini A; Longnecker R; Kieff E
J Virol; 1992 Aug; 66(8):4972-81. PubMed ID: 1321281
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter.
Swaminathan S
Virology; 1996 Mar; 217(2):532-41. PubMed ID: 8610445
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Cohen JI; Wang F; Mannick J; Kieff E
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
[TBL] [Abstract][Full Text] [Related]
10. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
Wang F; Marchini A; Kieff E
J Virol; 1991 Apr; 65(4):1701-9. PubMed ID: 1848303
[TBL] [Abstract][Full Text] [Related]
13. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
Aguirre AJ; Robertson ES
J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
[TBL] [Abstract][Full Text] [Related]
16. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
Mannick JB; Cohen JI; Birkenbach M; Marchini A; Kieff E
J Virol; 1991 Dec; 65(12):6826-37. PubMed ID: 1658376
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
Swaminathan S; Tomkinson B; Kieff E
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1546-50. PubMed ID: 1847527
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
19. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
[TBL] [Abstract][Full Text] [Related]
20. A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection.
Sixbey JW; Shirley P; Sloas M; Raab-Traub N; Israele V
J Infect Dis; 1991 May; 163(5):1008-15. PubMed ID: 1850440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]